Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

GI Cancer clinical trials

2 of 5 indexed GI Cancer trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

GI Cancer: 5 US clinical trials tracked, 2 recruiting.

GI Cancer is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Massachusetts General Hospital, running 2 of these trials.

Enrollment posture brief

Registry condition gi-cancer

OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%GI Cancer (this)40%
Open-enrollment share among volume-matched conditions near GI Cancer

GI Cancer lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for GI Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. GI Cancer is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates GI Cancer research.

    Massachusetts General Hospital accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical GI Cancer enrolment sits around 431 participants.

    Median target enrolment is 431 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. GI Cancer research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

Massachusetts General Hospital 2 trials
Avera McKennan Hospital & University Health Center 1 trials
The New York Proton Center 1 trials
Johns Hopkins University 1 trials

Named interventions

Most-linked intervention names on GI Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

TAILORED Patient Family Decision Making Other
1 trials
Pharmacy Intervention Other
1 trials
Proactive Psychiatry Consultation (PPC) Other
1 trials
standard of care Other
1 trials
Pencil Beam Scanning Proton Therapy Radiation
1 trials
Usual Care Other
1 trials

US sites by state

Facility locations filed on GI Cancer trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
South Dakota 1 trials
New York 1 trials
Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this GI Cancer page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This GI Cancer condition card totals 5 registered trials; most-linked intervention TAILORED Patient Family Decision Making; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.